Ad is loading...
ASPHF
Price
$2.69
Change
-$0.00 (-0.00%)
Updated
May 13 closing price
CMVLF
Price
$2.54
Change
-$0.00 (-0.00%)
Updated
May 21 closing price
Ad is loading...

ASPHF vs CMVLF

Header iconASPHF vs CMVLF Comparison
Open Charts ASPHF vs CMVLFBanner chart's image
ASCENTAGE PHARMA GROUP
Price$2.69
Change-$0.00 (-0.00%)
Volume$1K
CapitalizationN/A
Cellectis Romainville
Price$2.54
Change-$0.00 (-0.00%)
Volume$200
CapitalizationN/A
ASPHF vs CMVLF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASPHF vs. CMVLF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASPHF is a Buy and CMVLF is a Buy.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ASPHF: $2.69 vs. CMVLF: $2.54)
Brand notoriety: ASPHF and CMVLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASPHF: 100% vs. CMVLF: 100%
Market capitalization -- ASPHF: $1.72B vs. CMVLF: $186.1M
ASPHF [@Biotechnology] is valued at $1.72B. CMVLF’s [@Biotechnology] market capitalization is $186.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASPHF’s FA Score shows that 0 FA rating(s) are green whileCMVLF’s FA Score has 1 green FA rating(s).

  • ASPHF’s FA Score: 0 green, 5 red.
  • CMVLF’s FA Score: 1 green, 4 red.
According to our system of comparison, CMVLF is a better buy in the long-term than ASPHF.

Price Growth

ASPHF (@Biotechnology) experienced а 0.00% price change this week, while CMVLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ASPHF($1.72B) has a higher market cap than CMVLF($186M). CMVLF YTD gains are higher at: -15.050 vs. ASPHF (-16.199).
ASPHFCMVLFASPHF / CMVLF
Capitalization1.72B186M924%
EBITDAN/A-53.63M-
Gain YTD-16.199-15.050108%
P/E RatioN/AN/A-
RevenueN/A13M-
Total CashN/A273M-
Total DebtN/A91.2M-
FUNDAMENTALS RATINGS
CMVLF: Fundamental Ratings
CMVLF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
71
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYEIX273.24-2.12
-0.77%
Rydex Energy Inv
CBEAX13.86-0.11
-0.79%
Allspring Large Cap Value CL A
NYVCX23.59-0.23
-0.97%
Davis NY Venture C
FCUCX19.37-0.25
-1.27%
NYLI PineStone U.S. Equity Class C
EKBCX14.31-0.22
-1.51%
Allspring Diversified Cap Bldr C

ASPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with CGEN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASPHF
1D Price
Change %
ASPHF100%
N/A
CGEN - ASPHF
41%
Loosely correlated
-5.37%
CLLS - ASPHF
34%
Loosely correlated
-2.09%
CMVLF - ASPHF
34%
Loosely correlated
N/A
NURPF - ASPHF
30%
Poorly correlated
N/A
ALDX - ASPHF
27%
Poorly correlated
-1.41%
More

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been closely correlated with CLLS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CMVLF jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
CLLS - CMVLF
78%
Closely correlated
-2.09%
ABCZF - CMVLF
59%
Loosely correlated
N/A
SLN - CMVLF
41%
Loosely correlated
-9.16%
ALDX - CMVLF
39%
Loosely correlated
-1.41%
CLGN - CMVLF
37%
Loosely correlated
-1.41%
More